GotoPER - Physicians' Education Resource
Back to Home
Video

Module 2: Acute Myeloid Leukemia

Create AccountAlready Registered? Login Here

Release Date

April 16, 2026

Expiration Date

March 1, 2027

Credits

1.50 CME, NCPD

Specialties

Hematologic Cancer, Hematology

Activity Overview

This educational activity is an archive of the live conference held from February 26, 2026, through February 28, 2026.

Target Audience 

This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.

Learning Objectives

Upon participation in this activity, learners will be better able to:

  • Evaluate recent clinical trial results on approved and emerging therapeutic approaches for patients with hematologic disorders
  • Interpret the latest guidelines and evidence for the use of biomarker-driven strategies to stratify risk and select appropriate therapies for patients with hematologic disorders
    Module 2: Acute Myeloid Leukemia

    GET STARTED WITH THIS PROGRAM:

    Register now to gain access to this program.

    Create AccountAlready Registered? Login Here

    Click Here to return to Learning Hub

    Accreditation/Credit Designation

    Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.50 Contact Hours.

    Acknowledgment of Commercial Support

    This activity is supported by educational grants from Ascentage Pharma Inc; AstraZeneca Pharmaceuticals; Autolus Therapeutics; Daiichi Sankyo, Inc; Janssen Scientific Affairs, LLC; Novartis Pharmaceuticals Corporation; PharmaEssentia; Rigel Pharmaceuticals, Inc; and Sanofi.

    Follow Us on Social Media!

    Related Content

    Course

    Module 2: Acute Myeloid Leukemia

    Create Account